Case number 1:22-cv-00299
Novo Nordisk Inc. et al v. Alvogen, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 5, 2022 | 23 | CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 08/05/2022 - Associated DE Cases: CA 22-cv-294-CFC, CA 22-cv-296-CFC, CA 22-cv-297-CFC, CA 22-cv-298-CFC, CA 22-cv-299-CFC.(smg) (Entered: 08/08/2022) (5) |
| Jun 30, 2022 | 22 | Scheduling Order (30) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 22-294-CFC ONLY. Joinder of Parties due by 8/1/2023. Amended Pleadings due by 8/1/2023. Fact Discovery completed by 10/20/2023. Expert Discovery due by 5/24/2024. Joint Claim Construction Brief due by 5/1/2023. A Markman Hearing is set for 6/29/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 8/29/2024. A Final Pretrial Conference is set for 9/19/2024 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/30/2024 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/29/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 30, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:22-cv-00294-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-294-CFC ONLY. (nmf) |
| Jun 29, 2022 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 6/29/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 27, 2022 | 21 | [Proposed] Scheduling Order (38) |
| Jun 27, 2022 | 21 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding the Court's June 6, 2022 Order - re (19 in 1:22-cv-00294-CFC, 21 in 1:22-cv-00298-CFC, 19 in 1:22-cv-00296-CFC, 20 in 1:22-cv-00299-CFC, 25 in 1:22-cv-00297-CFC) Order Setting Scheduling Conference,. (Attachments: # (1) [Proposed] Scheduling Order)(Egan, Brian) |
| Jun 6, 2022 | 20 | Order Setting Scheduling Conference (3) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/29/2022 at 04:00 PM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 6/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| Jun 3, 2022 | 19 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding coordinated discovery and Markman proceedings - re (13 in 1:22-cv-00296-CFC, 13 in 1:22-cv-00296-CFC, 15 in 1:22-cv-00294-CFC, 15 in 1:22-cv-00294-CFC, 19 in 1:22-cv-00297-CFC, 19 in 1:22-cv-00297-CFC, 15 in 1:22-cv-00299-CFC, 15 in 1:22-cv-00299-CFC, 17 in 1:22-cv-00298-CFC, 17 in 1:22-cv-00298-CFC) Order,,, Set Deadlines,,. (Egan, Brian) |
| May 31, 2022 | 18 | Answer to Counterclaim (17) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim - by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| May 24, 2022 | 17 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Kara Czekai as co-counsel. Reason for request: No longer with firm. (Egan, Brian) |
| May 18, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Chantelle D. Ankerman, Matthew J. Becker, and Joshua S. Reisberg for Alvogen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| May 18, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Chantelle Ankerman, and Joshua S. Reisberg, filed by Alvogen, Inc. Ordered by Judge Colm F. Connolly on 5/18/2022. (kmd) |
| May 17, 2022 | 16 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Chantelle Ankerman, and Joshua S. Reisberg - filed by Alvogen, Inc.. (Keller, Karen) |
| May 11, 2022 | 15 | Order (3) Docket Text: ORDER: IT IS ORDERED that, on or before June 13, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/13/2022.) Signed by Judge Colm F. Connolly on 5/11/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC(nmf) |
| May 10, 2022 | 14 | SO ORDERED (2) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME for Defendant to produce a copy of its Abbreviated New Drug Application to Plaintiffs to May 16, 2022, filed by Alvogen, Inc. Signed by Judge Colm F. Connolly on 5/10/2022. (kmd) |
| May 9, 2022 | 11 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Alvogen, Inc..(Keller, Karen) |
| May 9, 2022 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Pharma US, Inc. for Alvogen, Inc. filed by Alvogen, Inc.. (Keller, Karen) |
| May 9, 2022 | 13 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding JPML filing. (Attachments: # (1) Attachment)(Egan, Brian) |
| May 9, 2022 | 13 | Attachment (1209) |
| May 9, 2022 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant to produce a copy of its Abbreviated New Drug Application to Plaintiffs to May 16, 2022 - filed by Alvogen, Inc.. (Keller, Karen) |
| May 6, 2022 | 9 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| May 6, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:22-cv-00298-CFC, 10 in 1:22-cv-00294-CFC, 13 in 1:22-cv-00297-CFC, 10 in 1:22-cv-00296-CFC, 9 in 1:22-cv-00299-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter, Kara Czekai, and Olivia Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/6/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (kmd) |
| Mar 25, 2022 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the complaint to May 9, 2022 - filed by Alvogen, Inc.. (DiBenedetto, Emily) |
| Mar 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the complaint to May 9, 2022 filed by Alvogen, Inc., Set/Reset Answer Deadlines: Alvogen, Inc. answer due 5/9/2022. Signed by Judge Colm F. Connolly on 3/25/2022. (nmf) |
| Mar 9, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00294-CFC through 1:22-cv-00299-CFC (rjb) |
| Mar 7, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Alvogen, Inc. served on 3/7/2022, answer due 3/28/2022. (Egan, Brian) |
| Mar 4, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Alvogen, Inc. on 3/4/2022. (mal) |
| Mar 4, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo A/S for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mal) |
| Mar 4, 2022 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,129,343 B2 ;9,132,239 B2 ;9,457,154 B2 ;9,687,611 B2 ;10,335,462 B2. (mal) |
| Mar 4, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/08/22. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 6/5/2025. (mal) |
| Mar 4, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Mar 4, 2022 | 1 | Civil Cover Sheet (1) |
| Mar 4, 2022 | 1 | Exhibit A-J (207) |
| Mar 4, 2022 | 1 | Complaint* (1) |
| Mar 4, 2022 | 1 | Main Document (16) Docket Text: COMPLAINT filed against Alvogen, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3817732.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibit A-J, # (2) Civil Cover Sheet)(mal) |
